Evidence map›Paper›PMID 29849881›Full record

ArticleOxidative medicine and cellular longevity2018

Effects of Vitamin D3 on the NADPH Oxidase and Matrix Metalloproteinase 9 in an Animal Model of Global Cerebral Ischemia.

Milica Velimirović, Gordana Jevtić Dožudić, Vesna Selaković, Tihomir Stojković, Nela Puškaš, Ivan Zaletel, Milica Živković, Vesna Dragutinović, Tatjana Nikolić, Ankica Jelenković and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Vitamin D3 and Ischemic Stroke: A Narrative Review.Antioxidants (Basel, Switzerland) · 2022
    Review
  11. Article
  12. Article
  13. Article
  14. Nutrients · 2021
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Indian journal of pharmacology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Milica VelimirovićInstitute of Clinical and Medical Biochemistry, School of Medicine, University of Belgrade, Pasterova 2, Belgrade, Serbia.ORCID 0000-0002-0495-0316
Gordana Jevtić DožudićInstitute of Clinical and Medical Biochemistry, School of Medicine, University of Belgrade, Pasterova 2, Belgrade, Serbia.
Vesna SelakovićMilitary Medical Academy, Crnotravska 17, Belgrade, Serbia.ORCID 0000-0002-9087-1525
Tihomir StojkovićInstitute of Clinical and Medical Biochemistry, School of Medicine, University of Belgrade, Pasterova 2, Belgrade, Serbia.ORCID 0000-0002-2400-6066
Nela PuškašInstitute of Histology and Embryology "Aleksandar Đ. Kostić", School of Medicine, University of Belgrade, Pasterova 2, Belgrade, Serbia.ORCID 0000-0002-5921-974X
Ivan ZaletelInstitute of Histology and Embryology "Aleksandar Đ. Kostić", School of Medicine, University of Belgrade, Pasterova 2, Belgrade, Serbia.ORCID 0000-0002-4841-788X
Milica ŽivkovićInstitute of Clinical and Medical Biochemistry, School of Medicine, University of Belgrade, Pasterova 2, Belgrade, Serbia.ORCID 0000-0002-1090-1887
Vesna DragutinovićInstitute of Medical Chemistry, School of Medicine, University of Belgrade, Belgrade, Serbia.
Tatjana NikolićInstitute of Clinical and Medical Biochemistry, School of Medicine, University of Belgrade, Pasterova 2, Belgrade, Serbia.ORCID 0000-0002-2185-7551
Ankica JelenkovićInstitute for Biological Research "Siniša Stanković", University of Belgrade, Belgrade, Serbia.ORCID 0000-0003-1980-2399
Djordje DjorovićInstitute of Anatomy "Niko Miljanić", School of Medicine, University of Belgrade, Dr Subotića 4, Belgrade, Serbia.ORCID 0000-0003-0984-1343
Aleksandar MirčićInstitute of Histology and Embryology "Aleksandar Đ. Kostić", School of Medicine, University of Belgrade, Pasterova 2, Belgrade, Serbia.
Nataša D PetronijevićInstitute of Clinical and Medical Biochemistry, School of Medicine, University of Belgrade, Pasterova 2, Belgrade, Serbia.ORCID 0000-0002-4338-1953
University of Belgrade · RSMilitary Medical Academy · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Decreased blood flow in the brain leads to a rapid increase in reactive oxygen species (ROS). NADPH oxidase (NOX) is an enzyme family that has the physiological function to produce ROS. NOX2 and NOX4 overexpression is associated with aggravated ischemic injury, while NOX2/4-deficient mice had reduced stroke size. Dysregulation of matrix metalloproteinases (MMPs) contributes to tissue damage. The active form of vitamin D3 expresses neuroprotective, immunomodulatory, and anti-inflammatory effects in the CNS. The present study examines the effects of the vitamin D3 pretreatment on the oxidative stress parameters and the expression of NOX subunits, MMP9, microglial marker Iba1, and vitamin D receptor (VDR), in the cortex and hippocampus of Mongolian gerbils subjected to ten minutes of global cerebral ischemia, followed by 24 hours of reperfusion. The ischemia/reperfusion procedure has induced oxidative stress, changes in the expression of NOX2 subunits and MMP9 in the brain, and increased MMP9 activity in the serum of experimental animals. Pretreatment with vitamin D3 was especially effective on NOX2 subunits, MMP9, and the level of malondialdehyde and superoxide anion. These results outline the significance of the NOX and MMP9 investigation in brain ischemia and the importance of adequate vitamin D supplementation in ameliorating the injury caused by I/R.

Indexed as

AnimalsBrain IschemiaCholecalciferolDisease Models, AnimalGerbillinaeMaleMatrix Metalloproteinase 9NADPH OxidasesCholecalciferolMatrix Metalloproteinase 9NADPH Oxidases

Identifiers

PMID29849881
PMCPMC5932460
OpenAlexW2802722373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.